Learn more about our Advocacy work.
WASHINGTON, D.C. – This week, AdvaMed® President and CEO Scott Whitaker welcomed progress from President Joe Biden on the White House Cancer Moonshot, including appointing new members to the President’s Cancer Cabinet…
This week, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, sent a letter urging House Energy and Commerce and Senate Health, Education, Labor and…
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed®’s Scott Whitaker on The Medtech POV podcast for a conversation on several policy initiatives.
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
The Advanced Medical Technology Association® (AdvaMed®) welcomes House passage of the MDUFA V agreement.
Scott Whitaker, president and CEO of AdvaMed®, the world’s largest trade association representing medical technology companies, released the following statement on progress this week in both houses of Congress.
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association® (AdvaMed®) released this statement from President and CEO Scott Whitaker.
AdvaMed®’s PAC is the voluntary, bipartisan Political Action Committee (PAC) of the Advanced Medical Technology Association®.
Scott Whitaker, President and CEO of AdvaMed®, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the…